The 6th company to come out ophthalmology incubator ForSight Labs said this month that it raised $3.0 million from a syndicate of 5 unnamed investors.
Stealthy ForSight Vision6 revealed the equity round in a Dec. 6 regulatory filing.
Last spring Menlo Park, Calif.-based ForSight Vision6 reported a round worth $1 million from a lone backer, just a few weeks after ForSight raised $15 million in a Series C round for its Vision5 project, the Helios ocular implant.
Since then the company has evidently made a change in the corner office. The May 4 filing listed ForSight Labs president & CEO Angela Macfarlane as the spinout’s CEO, but the filing this month listed ForSight Labs co-founder & vice chairman Dr. Eugene de Juan Jr. as ForSight Vision6’s chief executive.
Macfarlane is still listed as a director of the company, according to the filing.
